ATE387222T1 - Radioliganden- und bindungs-assay - Google Patents
Radioliganden- und bindungs-assayInfo
- Publication number
- ATE387222T1 ATE387222T1 AT01955807T AT01955807T ATE387222T1 AT E387222 T1 ATE387222 T1 AT E387222T1 AT 01955807 T AT01955807 T AT 01955807T AT 01955807 T AT01955807 T AT 01955807T AT E387222 T1 ATE387222 T1 AT E387222T1
- Authority
- AT
- Austria
- Prior art keywords
- radioligand
- binding assay
- hydoxyspiro
- naphthalenyl
- methanesulfonamide
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21839700P | 2000-07-14 | 2000-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE387222T1 true ATE387222T1 (de) | 2008-03-15 |
Family
ID=22814940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01955807T ATE387222T1 (de) | 2000-07-14 | 2001-07-10 | Radioliganden- und bindungs-assay |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6838291B2 (de) |
| EP (1) | EP1311300B1 (de) |
| JP (1) | JP2004512268A (de) |
| AT (1) | ATE387222T1 (de) |
| AU (1) | AU2001277863A1 (de) |
| CA (1) | CA2415295C (de) |
| DE (1) | DE60133010T2 (de) |
| ES (1) | ES2300345T3 (de) |
| WO (1) | WO2002005860A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003021271A2 (en) * | 2001-09-04 | 2003-03-13 | Pfizer Limited | Affinity-assay for the human erg potassium channel |
| GB0121440D0 (en) * | 2001-09-04 | 2001-10-24 | Pfizer Ltd | Assay |
| US6743797B2 (en) * | 2002-02-22 | 2004-06-01 | Chantest, Inc. | Methods for treating cardiac arrhythmia |
| FR2865540A1 (fr) * | 2003-05-20 | 2005-07-29 | Commissariat Energie Atomique | Procede de detection de fluorure ou de fluorure d'hydrogene et trousse de detection |
| SE0302775D0 (sv) * | 2003-10-20 | 2003-10-20 | Astrazeneca Ab | Chemical compound and assay |
| US7927820B2 (en) | 2004-07-20 | 2011-04-19 | Janssen Pharmaceutica Nv | Assay systems and methods for detecting molecules that interact with membrane channels |
| US7326772B2 (en) * | 2005-05-12 | 2008-02-05 | Penta Biotech, Inc. | Peptide for assaying hERG channel binding |
| US8133695B2 (en) * | 2008-02-28 | 2012-03-13 | Life Technologies Corporation | Fluorescence polarization hERG assay |
| EP2264026A4 (de) | 2008-03-06 | 2012-03-28 | Msd Kk | Alkylaminopyridinderivate |
| US10412788B2 (en) | 2008-06-13 | 2019-09-10 | Lg Chem, Ltd. | Heating element and manufacturing method thereof |
| US20110236907A1 (en) * | 2008-06-17 | 2011-09-29 | Wei Chen | Radiolabled cyclopamine assay for the smoothened receptor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| US5382587A (en) * | 1993-06-30 | 1995-01-17 | Merck & Co., Inc. | Spirocycles |
| WO1995023146A1 (en) * | 1994-02-25 | 1995-08-31 | Merck & Co., Inc. | Morphological forms of (+)-n-[1'-(6-cyano-1,2,3,4-tetrahydro-2-naphthalenyl)-3,4-dihydro-4-hydroxyspiro[2h-1-benzopyran-2,4'-piperidin]yl]methanesulfonamide hydrochloride |
| WO1997022367A1 (en) * | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
-
2001
- 2001-07-10 AT AT01955807T patent/ATE387222T1/de not_active IP Right Cessation
- 2001-07-10 ES ES01955807T patent/ES2300345T3/es not_active Expired - Lifetime
- 2001-07-10 WO PCT/US2001/021731 patent/WO2002005860A1/en not_active Ceased
- 2001-07-10 AU AU2001277863A patent/AU2001277863A1/en not_active Abandoned
- 2001-07-10 CA CA2415295A patent/CA2415295C/en not_active Expired - Fee Related
- 2001-07-10 DE DE60133010T patent/DE60133010T2/de not_active Expired - Lifetime
- 2001-07-10 JP JP2002511791A patent/JP2004512268A/ja active Pending
- 2001-07-10 EP EP01955807A patent/EP1311300B1/de not_active Expired - Lifetime
- 2001-07-12 US US09/904,045 patent/US6838291B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1311300A4 (de) | 2004-11-03 |
| EP1311300B1 (de) | 2008-02-27 |
| AU2001277863A1 (en) | 2002-01-30 |
| DE60133010T2 (de) | 2009-03-19 |
| DE60133010D1 (de) | 2008-04-10 |
| CA2415295A1 (en) | 2002-01-24 |
| WO2002005860A1 (en) | 2002-01-24 |
| EP1311300A1 (de) | 2003-05-21 |
| US20020034730A1 (en) | 2002-03-21 |
| ES2300345T3 (es) | 2008-06-16 |
| US6838291B2 (en) | 2005-01-04 |
| JP2004512268A (ja) | 2004-04-22 |
| CA2415295C (en) | 2010-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE387222T1 (de) | Radioliganden- und bindungs-assay | |
| GEP20104997B (en) | Composition comprising anther2 antibodies | |
| IE852841L (en) | Tetrazole-substituted indole derivatives | |
| TR200001603T2 (tr) | Yeni bileşikler | |
| TR200002015T2 (tr) | Protein tirosin kinaz inhibitörleri olarak bisiklik heteroaromatik bileşikler. | |
| DE3681991D1 (de) | Hmg-coa-reduktase-hemmungskoerper. | |
| FI20030162A7 (fi) | Uusia yhdisteitä | |
| WO1999020756A3 (en) | Human toll homologues | |
| PT1237584E (pt) | Conjugados de liga??o a receptor | |
| AU3669199A (en) | Methods of identifying and using hla binding compounds as hla-agonists and antagonists | |
| WO2002012224A3 (en) | Bicyclic compounds as h3 receptor ligands | |
| SV1999000060A (es) | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv | |
| FR2770517B1 (fr) | Laitier de cimentation d'un puits, notamment d'un puits petrolier | |
| AR028648A1 (es) | Derivados de 1,4-diazabiciclo[3.2.2]nonano-fenilisoxazol, su preparacion y su aplicacion en terapéutica | |
| PT978284E (pt) | Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina | |
| WO2003024183A3 (en) | Wortmannin analogs and methods of using same | |
| TR199900762T2 (xx) | Stresle aktifle�tirilen protein kinazlar�n�n engellenme y�ntemi. | |
| TR199800164T1 (xx) | Farmakolojide yararl� norbenzomorfan haz�rlanmas�. | |
| WO2001082871A3 (en) | Method of using zinc isotope for therapy and diagnosis of colon cancer | |
| TR199700547A2 (xx) | N-asetonilbenzamid fungisitler. | |
| WO1999005521A3 (de) | Konjugat zur unterscheidung von krankhaftem und gesundem gewebe | |
| WO2001017958A3 (en) | Neuropeptide sf receptor assays, compounds and therapeutic methods | |
| ATE320818T1 (de) | Mittel zur identifizierung und therapie metastasierender tumore | |
| HU9602157D0 (en) | Cyclic neurokinin a antagonists | |
| AR020785A1 (es) | Nuevos procedimientos quimicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |